Silent liver disease unmasked: new study targets early PBC detection
NCT ID NCT07205874
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 29 times
Summary
This study looks for early signs of primary biliary cholangitis (PBC) in people who have a specific antibody (AMA) but normal liver enzyme levels (ALP). Researchers will perform a liver biopsy and special blood tests on 80 adults to find factors that predict PBC before it causes damage. The goal is to diagnose the disease earlier, when treatment may be more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario La Paz
RECRUITINGMadrid, 28046, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.